AZO YEAST PLUS 20 CT Recalled Due to Improper Storage Conditions
AZO YEAST PLUS 20 CT has been recalled by Family Dollar Stores due to improper storage temperature conditions that violate CGMP requirements. The product was distributed nationwide from April through June 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for storage temperature deviations (CGMP violation). No illnesses or injuries have been reported. The hazard is the potential impact of improper storage on product integrity, which is a theoretical risk without documented harm.
Plain-English summary
Family Dollar Stores, LLC is recalling AZO YEAST PLUS 20 CT nationwide due to a Current Good Manufacturing Practice (CGMP) violation. The product was held outside the appropriate storage temperature conditions required for dietary supplements.
The affected product, identified by SKU 902787, was distributed to Family Dollar Stores across the United States between April 30, 2022 and June 10, 2022. The improper storage may have affected the product's integrity and safety.
Consumers who purchased this product should discontinue use. This is an FDA Class II recall.
The recalled product
- Product
- AZO YEAST PLUS 20 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Dietary Supplement
- Hazard
- improper-storage
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902787
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27